"Without question, BioAdvance funding was a critical ingredient for the launch of Melior Discovery. There was simply no comparable funding source for a startup entity such as ours. Melior would not exist today, would not have discovered a new class of candidate diabetes therapeutics, and would not have uncovered new clinical candidates for our pharma partners were it not for funding conduit provided by BioAdvance."
Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA
Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA
News Releases
| 2010 | | | 2009 | | | 2008 | | | 2007 | | | 2006 | | | 2005 | | | 2004 | | | 2003 | | | 2002 | | | 2001 |
2007
|
November 26, 2007 Yaupon Therapeutics Closes $14.5 Million Financing -- Series C financing positions company to advance development of its portflio targeting cancer and central nervous system diseases |
| > View Press Release |
|
October 3, 2007 Avid Announces Clinical Trial of Imaging Compound for Detection of Parkinson's Disease and Lewy Body Dementia |
| > View Press Release |
|
August 23, 2007 CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment of Erythema (SansRosa) |
| > View Press Release |
|
August 2, 2007 Melior Discovery Enters New Pharmaceutical Collaboration |
| > View Press Release |
|
July 31, 2007 SonoSite Announces Acquisition of Catheter Guidance Technology |
| > View Press Release |
|
June 8, 2007 NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine |
| > View Press Release |
|
May 9, 2007 Avid Radiopharmaceuticals Closes $26M Series C Financing |
| > View Press Release |
|
March 12, 2007 Greater Philadelphia Launches Online Database of Resources for the Region's Life Science Industry |
| > View Press Release |
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.